Vitamin B12, Vitamin E and Folic Acid: study protocols
20 study groups took Vitamin B12 together with Vitamin E and Folic Acid. These are the doses the studies gave. They are not a recommendation.
Dose per serving from research: Vitamin B12
20 study groups in 15 studies say how much Vitamin B12 participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 2.5 mcg to 5 mcg, 35% of 20 study groups.
| Daily dose | Study groups |
|---|---|
| 1 mcg or less | 1 |
| 1 mcg to 2.5 mcg | 1 |
| 2.5 mcg to 5 mcg | 7 |
| 5 mcg to 10 mcg | 4 |
| 10 mcg to 25 mcg | 1 |
| 25 mcg to 50 mcg | 2 |
| 50 mcg to 100 mcg | 0 |
| 100 mcg to 250 mcg | 0 |
| 250 mcg to 500 mcg | 1 |
| 500 mcg to 1 mg | 3 |
Dose per serving from research: Vitamin E
15 study groups in 12 studies say how much Vitamin E participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 25 mg to 50 mg, 33% of 15 study groups.
| Daily dose | Study groups |
|---|---|
| 5 mg or less | 1 |
| 5 mg to 10 mg | 4 |
| 10 mg to 25 mg | 3 |
| 25 mg to 50 mg | 5 |
| 50 mg to 100 mg | 1 |
| 100 mg to 250 mg | 0 |
| over 250 mg | 1 |
Dose per serving from research: Folic Acid
20 study groups in 15 studies say how much Folic Acid participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 250 mcg to 500 mcg, 50% of 20 study groups.
| Daily dose | Study groups |
|---|---|
| 100 mcg or less | 1 |
| 100 mcg to 250 mcg | 2 |
| 250 mcg to 500 mcg | 10 |
| 500 mcg to 1 mg | 5 |
| 1 mg to 2.5 mg | 0 |
| 2.5 mg to 5 mg | 2 |
Commonly used together
20 of 20 study groups took Vitamin B12, Vitamin E and Folic Acid with something else. Shown: what 3 or more different studies gave. The 10 most common of 12.
What was given together, not what works together.
| Taken with | Study groups |
|---|---|
| Vitamin B6 | 13 |
| Vitamin C | 12 |
| Zinc | 10 |
| Copper | 9 |
| Vitamin A | 9 |
| Iron | 8 |
| Selenium | 8 |
| Thiamine | 8 |
| Vitamin D | 8 |
| Riboflavin | 7 |
20 study groups
| Study | |||||
|---|---|---|---|---|---|
| Effects of a nutritional supplement on the immune response and cytokine production in free-living Chilean elderly 2004 · special nutritional formula · Healthy adults aged 70 years or older with Mini Mental score ≥22 | 3.8 mcg | 120 IU | 400 mcg | 1 year | 30 |
| Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal 2003 · Multiple micronutrients · Pregnant women in rural Nepal | 2.6 mcg | 10 mg | 400 mcg | — | — |
| Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension 2005 · Multivitamin plus vitamin A · HIV-positive pregnant Tanzanian women | 50 mcg | 30 mg | 800 mcg | — | — |
| Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension 2005 · Multivitamin without vitamin A · HIV-positive pregnant Tanzanian women | 50 mcg | 30 mg | 800 mcg | — | — |
| A smartphone application to improve adherence to vitamin and mineral supplementation after bariatric surgery 2022 · Intervention group · Adults aged over 18 to 60 years undergoing gastric bypass or sleeve gastrectomy | 1 mg | 8 mg | 400 mcg | 1 year | 71 |
| A smartphone application to improve adherence to vitamin and mineral supplementation after bariatric surgery 2022 · Control group · Adults aged over 18 to 60 years undergoing gastric bypass or sleeve gastrectomy | 1 mg | 8 mg | 400 mcg | 1 year | 69 |
| A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia 2010 · NF group, 3-month blinded trial · Community-dwelling adults aged 18–86 years, both sexes, without dementia or clinical memory difficulties | 6 mcg | 30 IU | 400 mcg | 90 days | 59 |
| Effects of Low-Dose Dairy Protein Plus Micronutrient Supplementation during Resistance Exercise on Muscle Mass and Physical Performance in Older Adults: A Randomized, Controlled Trial 2018 · ExPM (resistance exercise plus low-dose dairy protein and micronutrient supplementation) · Adults aged 65–80 years, non-disabled and not exercising regularly | 12 mcg | 30 mg | 200 mcg | 12 weeks | 40 |
| A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia 2010 · Open-label NF group, separate 6-month trial · Community-dwelling adults, both sexes, without dementia or clinical memory difficulties | 6 mcg | 30 IU | 400 mcg | 26 weeks | 38 |
| A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia 2010 · NF group, 2-week blinded trial · Community-dwelling adults, both sexes, without dementia or clinical memory difficulties | 6 mcg | 30 IU | 400 mcg | 2 weeks | — |
| Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation 2011 · Group MVB · Patients with type 2 diabetes | 10 mcg | 100 mg | 1 mg | 120 days | — |
| Antenatal Multiple Micronutrient Supplementation Compared to Iron-Folic Acid Affects Micronutrient Status but Does Not Eliminate Deficiencies in a Randomized Controlled Trial Among Pregnant Women of Rural Bangladesh 2019 · MM · Pregnant women aged 12–45 years in rural Bangladesh | 2.6 mcg | 15 mg | 600 mcg | 165 days | 749 |
| Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease 2015 · Active group (RCT1, RCT2 and RCT3) · Men and women aged 50 years or older with mild or mild-to-moderate Alzheimer's disease; RCT3 participants were on stable approved Alzheimer's medication, while RCT1 and RCT2 participants were drug-free for Alzheimer's medication. | 3 mcg | 40 mg | 400 mcg | 24 weeks | 501 |
| Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease 2015 · Active product during open-label extension (OLE) · Men and women aged 50 years or older with mild Alzheimer's disease who completed RCT2. | 3 mcg | 40 mg | 400 mcg | 24 weeks | 201 |
| Newborn micronutrient status biomarkers in a cluster-randomized trial of antenatal multiple micronutrient compared with iron folic acid supplementation in rural Bangladesh 2020 · MM · Pregnant women in rural Bangladesh; age range not specified; no disease condition specified | 2.6 mcg | 15 mg | 600 mcg | — | 176 |
| Daily supplementation of a multiple micronutrient powder improves folate but not thiamine, riboflavin, or vitamin B(12) status among young Laotian children: a randomized controlled trial 2022 · micronutrient powder group (MNP) · Children aged 6–23 months in rural Lao PDR; no disease-based selection, with high prevalence of undernutrition and micronutrient deficiencies | 0.9 mcg | 5 mg | 150 mcg | 36 weeks | 130 |
| Multiple micronutrient supplementation improves vitamin B₁₂ and folate concentrations of HIV infected children in Uganda: a randomized controlled trial 2011 · Multiple micronutrient supplementation (MMS) · HIV-infected children aged 1–5 years | 2.4 mcg | 14 mg | 40 mcg | 26 weeks | 104 |
| Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial 2006 · Antioxidant vitamins plus B-group vitamins · Acute ischemic stroke patients treated within 12 hours of symptom onset | 400 mcg | 800 IU | 5 mg | 2 weeks | 24 |
| A novel nutritional supplement to reduce plasma homocysteine in nonpregnant women: A randomised controlled trial in The Gambia 2019 · UNIMMAP tablet · Nonpregnant, non-lactating healthy women aged 18–45 years in West Kiang, The Gambia; women of reproductive age with common micronutrient deficiencies in the population | 2.6 mcg | 10 mg | 400 mcg | 12 weeks | 105 |
| Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD 2009 · Treatment group · Adults with stage 2 to 4 chronic kidney disease and creatinine clearance of 15 to 70 mL/min/1.73 m² | 1 mg | 300 mg | 5 mg | 2 years | 47 |